Treatments | Disease severity (%) | Disease incidence (%) | Disease control (%) | |
---|---|---|---|---|
Control | T1 | 0.00Â h | 0.00i | 100 |
Negative control | T2 | 98.35 ± 8.66a | 91.5 ± 5.33a | 8.53 |
Therapeutic plan | T3 | 25.87 ± 5.25f | 17.23 ± 2.65 g | 82.77 |
T4 | 44.63 ± 4.54e | 39.83 ± 2.88e | 60.17 | |
T5 | 63.56 ± 7.24c | 50.33 ± 3.53 cd | 49.67 | |
T6 | 72.54 ± 4.66b | 61.77 ± 2.75b | 38.23 | |
T7 | 39.55 ± 1.76e | 29.41 ± 3.88 | 70.59 | |
Protective plan | T8 | 18.76 ± 2.05 g | 7.16 ± 0.76 h | 92.84 |
T9 | 40.78 ± 4.56e | 35.33 ± 5.68e | 64.67 | |
T10 | 55.87 ± 3.78d | 48.67 ± 3.47d | 51.33 | |
T11 | 68.45 ± 4.66c | 54.39 ± 2.68c | 45.61 | |
T12 | 41.67 ± 1.21e | 26.16 ± 3.94f | 73.84 |